<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with long-standing <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) are at a higher risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This risk increases with the longer duration of <z:hpo ids='HP_0002583'>colitis</z:hpo>, greater extent of <z:mp ids='MP_0001845'>inflammation</z:mp>, a family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, severity of bowel <z:mp ids='MP_0001845'>inflammation</z:mp>, and a coexistent primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The cornerstone for comprehending the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in IBD and hence early detection is based on the understanding of the molecular pathways of IBD itself </plain></SENT>
<SENT sid="3" pm="."><plain>At a molecular level, the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is related to understanding the inflammatory changes and involves multiple inter-related pathways including (i) genetic alterations (e.g. chromosomal and microsatellite instability and hypermethylation), (ii) mucosal <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> (e.g. COX-2, interleukin-6, interleukin-23, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α, nuclear factor-κB, and chemokines), (iii) changes in the expression of receptors on the epithelial cells, and (iv) oxidant stress, mucosal breakdown, and intestinal microbiota </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this review is to provide an evidence-based approach for the role of <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory mechanisms and the molecular basis of these mechanisms in the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, understanding the molecular basis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is an important step for the identification of new biomarkers that can help in the early detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in these patients </plain></SENT>
</text></document>